Literature DB >> 24036104

The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress.

Taija S Koskenkorva-Frank1, Günter Weiss2, Willem H Koppenol3, Susanna Burckhardt4.   

Abstract

Production of minute concentrations of superoxide (O2(*-)) and nitrogen monoxide (nitric oxide, NO*) plays important roles in several aspects of cellular signaling and metabolic regulation. However, in an inflammatory environment, the concentrations of these radicals can drastically increase and the antioxidant defenses may become overwhelmed. Thus, biological damage may occur owing to redox imbalance-a condition called oxidative and/or nitrosative stress. A complex interplay exists between iron metabolism, O2(*-), hydrogen peroxide (H2O2), and NO*. Iron is involved in both the formation and the scavenging of these species. Iron deficiency (anemia) (ID(A)) is associated with oxidative stress, but its role in the induction of nitrosative stress is largely unclear. Moreover, oral as well as intravenous (iv) iron preparations used for the treatment of ID(A) may also induce oxidative and/or nitrosative stress. Oral administration of ferrous salts may lead to high transferrin saturation levels and, thus, formation of non-transferrin-bound iron, a potentially toxic form of iron with a propensity to induce oxidative stress. One of the factors that determine the likelihood of oxidative and nitrosative stress induced upon administration of an iv iron complex is the amount of labile (or weakly-bound) iron present in the complex. Stable dextran-based iron complexes used for iv therapy, although they contain only negligible amounts of labile iron, can induce oxidative and/or nitrosative stress through so far unknown mechanisms. In this review, after summarizing the main features of iron metabolism and its complex interplay with O2(*-), H2O2, NO*, and other more reactive compounds derived from these species, the potential of various iron therapies to induce oxidative and nitrosative stress is discussed and possible underlying mechanisms are proposed. Understanding the mechanisms, by which various iron formulations may induce oxidative and nitrosative stress, will help us develop better tolerated and more efficient therapies for various dysfunctions of iron metabolism.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACD; AID; ARE; DMT1; EPO; F-box and leucine-rich repeat protein 5; FBXL5; FCM; FG; FID; FMX; FPN; Fe-EDTA; Free radicals; GI; GPx; GSH; HIF; HO-1; Hb; ID(A); IIM; IL; IPC; IPCS; IRE; IRP; IS; ISS; Intravenous iron; LIP; LMWID; MDA; NF-E2-related factor 2; NTBI; Nitrosative stress; Nramp1; Nrf2; Oral iron; Oxidative stress; PHD; PSC; RNS; ROS; Reactive nitrogen species; Reactive oxygen species; SOD; Steap3; TNF-α; TRPML1; TSAT; TfR; UTR; VHL; absolute iron deficiency; anemia of chronic disease; antioxidant-responsive elements; asc; ascorbic acid; divalent metal transporter 1; eNOS; endothelial nitric oxide synthase; erythropoietin; ferric carboxymaltose; ferric gluconate; ferroportin; ferumoxytol; functional iron deficiency; gastrointestinal; glutathione; glutathione peroxidase; heme oxygenase 1; hemoglobin; hypoxia-inducible factor; iNOS; inducible nitric oxide synthase; interleukin; intravenous; iron deficiency (anemia); iron isomaltoside 1000; iron polymaltose complex; iron polymaltose complex similar; iron sucrose; iron sucrose similar; iron-regulatory element; iron-regulatory protein; iv; labile iron pool; low-molecular-weight iron dextran; malondialdehyde, MPS, mononuclear phagocyte system, NF-κB, nuclear factor-κB; nNOS; natural resistance-associated macrophage protein 1; neuronal nitric oxide synthase; non-transferrin-bound iron; polyglucose sorbitol carboxymethyl ether; prolyl hydroxylase; reactive nitrogen species; reactive oxygen species; six-transmembrane epithelial antigen of the prostate 3; sodium Fe(III) ethylenediaminetetraacetic acid; superoxide dismutase; transferrin receptor; transferrrin saturation; transient receptor potential cation channel, mucolipin subfamily, member 1; tumor necrosis factor α; untranslated region; von Hippel–Lindau

Mesh:

Substances:

Year:  2013        PMID: 24036104     DOI: 10.1016/j.freeradbiomed.2013.09.001

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  121 in total

Review 1.  Neurotoxicity Linked to Dysfunctional Metal Ion Homeostasis and Xenobiotic Metal Exposure: Redox Signaling and Oxidative Stress.

Authors:  Carla Garza-Lombó; Yanahi Posadas; Liliana Quintanar; María E Gonsebatt; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2018-03-28       Impact factor: 8.401

Review 2.  Anemia of inflammation.

Authors:  Guenter Weiss; Tomas Ganz; Lawrence T Goodnough
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

Review 3.  The crossroads of iron with hypoxia and cellular metabolism. Implications in the pathobiology of pulmonary hypertension.

Authors:  Jeffrey C Robinson; Brian B Graham; Tracey C Rouault; Rubin M Tuder
Journal:  Am J Respir Cell Mol Biol       Date:  2014-12       Impact factor: 6.914

4.  Dopamine-melanin nanoparticles scavenge reactive oxygen and nitrogen species and activate autophagy for osteoarthritis therapy.

Authors:  Gang Zhong; Xueyuan Yang; Xianfang Jiang; Anil Kumar; Huiping Long; Jin Xie; Li Zheng; Jinmin Zhao
Journal:  Nanoscale       Date:  2019-06-20       Impact factor: 7.790

5.  Plasma hepcidin is associated with future risk of venous thromboembolism.

Authors:  Trygve S Ellingsen; Jostein Lappegård; Thor Ueland; Pål Aukrust; Sigrid K Brækkan; John-Bjarne Hansen
Journal:  Blood Adv       Date:  2018-06-12

Review 6.  Perspective: What Makes It So Difficult to Mitigate Worldwide Anemia Prevalence?

Authors:  Klaus Schümann; Noel W Solomons
Journal:  Adv Nutr       Date:  2017-05-15       Impact factor: 8.701

7.  Snapshots of Iron Speciation: Tracking the Fate of Iron Nanoparticle Drugs via a Liquid Chromatography-Inductively Coupled Plasma-Mass Spectrometric Approach.

Authors:  Heather M Neu; Sergei A Alexishin; Joel E P Brandis; Anne M C Williams; Wenjing Li; Dajun Sun; Nan Zheng; Wenlei Jiang; Ann Zimrin; Jeffrey C Fink; James E Polli; Maureen A Kane; Sarah L J Michel
Journal:  Mol Pharm       Date:  2019-02-14       Impact factor: 4.939

8.  Iron Loading Exaggerates the Inflammatory Response to the Toll-like Receptor 4 Ligand Lipopolysaccharide by Altering Mitochondrial Homeostasis.

Authors:  Konrad Hoeft; Donald B Bloch; Jan A Graw; Rajeev Malhotra; Fumito Ichinose; Aranya Bagchi
Journal:  Anesthesiology       Date:  2017-07       Impact factor: 7.892

Review 9.  The Impact of Dietary Transition Metals on Host-Bacterial Interactions.

Authors:  Christopher A Lopez; Eric P Skaar
Journal:  Cell Host Microbe       Date:  2018-06-13       Impact factor: 21.023

10.  Safety Report of Ferumoxytol for Magnetic Resonance Imaging in Children and Young Adults.

Authors:  Anne M Muehe; Dan Feng; Rie von Eyben; Sandra Luna-Fineman; Michael P Link; Travis Muthig; Amy E Huddleston; Edward A Neuwelt; Heike E Daldrup-Link
Journal:  Invest Radiol       Date:  2016-04       Impact factor: 6.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.